Logo

TATAA Biocenter: Mathias Hallin, Kennet Mattsson, Kristofer Hellberg

Jun 23, 2023

Gothenburg, Sweden-based molecular biology research services organization TATAA Biocenter has appointed Mathias Hallin as CEO, Kennet Mattsson as senior VP of commercial operations, and Kristofer Hellberg as senior VP of laboratory services.

Hallin has been head of finance for TATAA Biocenter since November 2022. Before that, he was finance director for the Nordic and Baltic regions at the Van Ameyde Group. Mattsson previously served as head of sales and business development and business development manager at TATAA Biocenter. Earlier, he was district sales manager for the UK and Nordics at HTG Molecular Diagnostics. Hellberg has served as product manager for services at TATAA Biocenter since May 2022. Prior to that he was country manager for the Nordics with Eurofins Genomics.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.